Abstract

Within the context of increased health care spending in Italy and governmental cost-containment efforts, attention has focused on the medical device sector also in light of the newly introduced centralized procurement policy, of Health Technology Assessment, and of the Government’s call for a more managerial-type approach by public health authorities. In this scenario, it became necessary to analyse investments in medical devices and to assess their contribution not only to the health of patients, but also to – if any – the whole economy and to the nation’s economic growth. Public health authorities must now also assess the effect of investments on profitability by evaluating investment regenerations based on the diagnosis-related group revenue for inpatients and on the Regional tariffs established by the Italian National Health Service for outpatients. Knowledge of the medical device sector, and planning and control systems, will enable public health authorities to improve their internal decision-making ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call